[1]
F. Marotta, “A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome”, Acta Biomed, vol. 84, no. 1, pp. 53–60, Jun. 2013, Accessed: Jul. 15, 2024. [Online]. Available: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/2429